EP2989437A1 - Device for preparing biological samples - Google Patents
Device for preparing biological samplesInfo
- Publication number
- EP2989437A1 EP2989437A1 EP14726695.1A EP14726695A EP2989437A1 EP 2989437 A1 EP2989437 A1 EP 2989437A1 EP 14726695 A EP14726695 A EP 14726695A EP 2989437 A1 EP2989437 A1 EP 2989437A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tank
- filtration
- collection
- suction
- zone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012472 biological sample Substances 0.000 title claims abstract description 60
- 238000001914 filtration Methods 0.000 claims abstract description 228
- 238000011045 prefiltration Methods 0.000 claims description 131
- 239000012528 membrane Substances 0.000 claims description 93
- 244000005700 microbiome Species 0.000 claims description 79
- 238000000034 method Methods 0.000 claims description 23
- 238000002360 preparation method Methods 0.000 claims description 11
- 238000004891 communication Methods 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 9
- 210000002700 urine Anatomy 0.000 description 46
- 239000007788 liquid Substances 0.000 description 43
- 239000012141 concentrate Substances 0.000 description 21
- 241000588724 Escherichia coli Species 0.000 description 19
- 239000000523 sample Substances 0.000 description 19
- 239000000872 buffer Substances 0.000 description 17
- 108090000765 processed proteins & peptides Proteins 0.000 description 17
- 238000009640 blood culture Methods 0.000 description 16
- 102000004196 processed proteins & peptides Human genes 0.000 description 15
- 239000000470 constituent Substances 0.000 description 11
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 11
- 238000011084 recovery Methods 0.000 description 11
- 230000008901 benefit Effects 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 241000222122 Candida albicans Species 0.000 description 8
- 239000004695 Polyether sulfone Substances 0.000 description 8
- 230000009089 cytolysis Effects 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 229920006393 polyether sulfone Polymers 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 238000001972 liquid chromatography-electrospray ionisation mass spectrometry Methods 0.000 description 7
- 230000001575 pathological effect Effects 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 229940095731 candida albicans Drugs 0.000 description 6
- 210000001808 exosome Anatomy 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 230000000717 retained effect Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 5
- 239000008188 pellet Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000003306 harvesting Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- -1 polypropylene Polymers 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 238000005299 abrasion Methods 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000011534 wash buffer Substances 0.000 description 3
- QYOVMAREBTZLBT-KTKRTIGZSA-N CCCCCCCC\C=C/CCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO QYOVMAREBTZLBT-KTKRTIGZSA-N 0.000 description 2
- 241000588917 Citrobacter koseri Species 0.000 description 2
- 241000305071 Enterobacterales Species 0.000 description 2
- 241000588921 Enterobacteriaceae Species 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000006194 liquid suspension Substances 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 2
- 239000010813 municipal solid waste Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000002731 protein assay Methods 0.000 description 2
- 238000000751 protein extraction Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000012465 retentate Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- AFVLVVWMAFSXCK-UHFFFAOYSA-N α-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(C#N)=CC1=CC=C(O)C=C1 AFVLVVWMAFSXCK-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000008001 CAPS buffer Substances 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 229920002274 Nalgene Polymers 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 229920012266 Poly(ether sulfone) PES Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002313 adhesive film Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000012543 microbiological analysis Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- QHGVXILFMXYDRS-UHFFFAOYSA-N pyraclofos Chemical compound C1=C(OP(=O)(OCC)SCCC)C=NN1C1=CC=C(Cl)C=C1 QHGVXILFMXYDRS-UHFFFAOYSA-N 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 230000000754 repressing effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
- C12M33/04—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus by injection or suction, e.g. using pipettes, syringes, needles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
- C12M33/14—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus with filters, sieves or membranes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
Definitions
- the field of the present invention is that of microbiological analysis. More particularly, the present invention relates to a device for the preparation of biological sample for microbiological diagnosis. Vacuum filtration is conventionally used in laboratories. It is used in two ways:
- the filtrate is discarded, the concentrate (also called retentate) and / or the filter are preserved.
- FIG. One known device of the state of the art is the Buchner funnel. Such a device is shown in FIG. It comprises a funnel in which is arranged transversely a perforated plate. The funnel is sealed in the neck of a vacuum flask with a stopper. The vacuum flask is connected to a suction source. On the perforated plate is a filter paper moistened so that particles in a liquid poured on the upper part of the paper can be retained during suction. The filtered liquid, or filtrate, is collected in the vial.
- Such a device has several disadvantages. Indeed, the filter can clog quickly if the liquid contains too much particles or microorganisms which can prevent filtration of the entire volume.
- the large filtration area necessary to be able to filter a sufficient quantity of sample, may require the use of a large volume of liquid for the complete resuspension of the microorganisms retained on the filter, which not allow to have an optimal concentration ratio.
- the collection of particles of interest or microorganisms retained on the filter paper is difficult and requires the use of a swab manually. Swab recovery automatically is not easy to achieve in a reproducible manner.
- this type of device has a second disadvantageous release yield if the concentrate, especially bacterial, must be delivered in liquid form for the purposes of the analysis protocol.
- the dispensed liquid spreads over the entire surface of the filter, so it is difficult to aspirate it again.
- the sequence of a filtration protocol using this device can not be automated easily.
- Another device of the prior art described in the patent application US 2007/0298451 A1, comprises a lower filtration unit and a higher filtration unit.
- the upper filtration unit comprises a cylindrical wall of a first diameter and a cylindrical wall of a smaller diameter connected by a transverse part.
- the lower filtration unit comprises a cylindrical wall of a first diameter and a cylindrical wall of a smaller diameter connected by a transverse part.
- a perforated plate and a filtration membrane On the transverse part is arranged a perforated plate and a filtration membrane.
- a cylindrical wall of still smaller diameter is disposed downstream of the perforated plate and connected to the lower filtration block by a transverse portion, so as to connect a suction source to the device.
- the upper filter block is pushed onto the lower filter block.
- the membrane of the upper filtration block has a higher porosity than the membrane of the lower filtration block. Therefore, by pouring a liquid sample on the membrane of the upper filter block and activating the suction source, it is filtered a first and a second time.
- this device may have a better filtration efficiency, including progressive filtration, the dispensed liquid spreads over the entire surface of both membranes, making collection difficult.
- a blockage, even partial, of one or more membranes (s) can cause a loss of load during suction and slow down or even prevent filtration.
- the object of the invention is therefore to overcome the disadvantages of the aforementioned prior art.
- a first object of the present invention is thus to provide a biological sample treatment device for collecting the microorganisms contained in the sample by removing constituents of the matrix of the latter.
- constituents may be dissolved salts, proteins, crystals, mucous, human cells, or others.
- a second object of the invention is to provide a biological sample treatment device for rapid purification of microbial content for subsequent analysis as well as washing of the filter or collection membrane.
- a third object of the invention is to provide a biological sample treatment device for both concentrating microorganisms on the surface of the filter or the collection membrane and for resuspending the microorganisms thus concentrated, in one volume. limited buffer.
- a fourth object of the invention is to provide a biological sample processing device so that the steps of the processing protocol using the device can be performed in a fully automated manner by a suitable pipetting robot (eg Hamilton Robotics Starlet). ), also called a pipetting robot.
- a suitable pipetting robot eg Hamilton Robotics Starlet
- a fixed support whose base extends in a first plane
- a filter unit that can be removable, said filtration unit comprising a collection tank that itself comprises a wall and a filtration means, the filtration means extending in a second plane and dividing said collection tank into a zone; and a suction zone, the suction zone being adapted to be connected to a suction means, the second plane of the filter means being inclined relative to the plane of the base of the fixed support.
- the present invention relates to a device for the preparation of biological sample comprising:
- a fixed support whose base extends in a first plane
- a filter unit that can be removable, said filtration unit comprising a collection tank which itself comprises a filtration means extending in a second plane and dividing said collection tank into a collection zone and a suction zone; , the suction zone being adapted to be connected to a suction means, the second plane of the filtering means being inclined relative to the plane of the base of the fixed support.
- biological sample a liquid sample, likely to contain one or more constituents of interest, such as urine, blood cultures, sputum, cerebrospinal fluid, ....
- constituents of interest may be microorganisms such as yeast, bacteria, or micro-vesicles or exosomes.
- the subject of the invention is a device for the preparation of a biological sample comprising:
- a fixed support whose base extends in a first plane
- a filter unit that can be removable, said filtration unit comprising a collection tank itself having a filtration means extending in a second plane and dividing said collection reservoir into a collection zone and a suction zone, the suction zone being adapted to connected to a suction means, the second plane of the filtering means being inclined relative to the plane of the base of the fixed support, the filtration unit further comprises a pre-filtration tank that can be removable, said prefiltration tank comprising a filtration means dividing the prefiltration tank into a collection zone and a suction zone, the suction zone of the prefiltration tank being in fluid communication with the collection area of the collection tank.
- the subject of the invention is a device for the preparation of a biological sample comprising:
- a fixed support whose base extends in a first plane
- said filtration unit comprising a collection tank itself comprising a wall and a filtering means, the filtering means extending in a second plane and dividing said collection tank into a collection zone and a suction zone, the suction zone being adapted to be connected to a suction means, the second plane of the filtering means being inclined relative to the plane of the base of the fixed support, the filtration unit further comprises a prefiltration reservoir which can be removable, said prefiltration tank comprising a filtration means dividing the prefiltration tank into a collection zone and a suction zone, the suction zone of the prefiltration tank being in fluid communication with the collection zone of the collection tank .
- the suction zone of the prefiltration tank is adapted to be connected to a second suction means.
- the wall of the collection tank in the collection zone is partly inclined or ogival-shaped.
- the wall of the collection zone of the collection tank is partly inclined or ogival-shaped.
- the wall of the collection tank in the collection zone is rigid.
- the filtering means of the collection reservoir comprises at least one membrane with a porosity of between 0.02 and 1.5 ⁇ " ⁇ , preferably between 0.02 and ⁇ ⁇ , more preferably between 0.02 and ⁇ , ⁇ . , even more preferentially between 0.02 ⁇ and 0.45 ⁇
- the filtration means of the collection reservoir comprises at least one membrane with a porosity of between 0.02 ⁇ and 0.45 ⁇ .
- the filtration means of the prefiltration tank comprises at least one porosity filter of between 5 ⁇ and 1,000 ⁇ , preferably between 5 ⁇ and 100 ⁇ .
- the filtration means of the prefiltration tank comprises a stack of filters.
- the filtration means of the prefiltration tank comprises a stack of filters of increasing porosity from the suction zone of the prefiltration tank to the collection zone of the prefiltration tank.
- the filtration means of the prefiltration tank comprises or consists of a stack of prefilters of increasing porosity in order from bottom to top, the prefilter placed at the top being the first to receive the liquid.
- the second plane of the filtering means of the collection tank is inclined relative to the plane of the base of the fixed support at an angle of between 10 ° and 60 °, preferably between 20 ° and 50 °, of preferably between 25 ° and 45 °, more preferably equal to 30 °.
- the collection reservoir comprises an upper portion and a lower portion cooperating to maintain the filtration means of the collection tank
- the prefiltration tank comprises an upper part and a lower part cooperating to maintain the filtering means of the prefiltration tank
- the prefiltration tank comprises means capable of cooperating with a pipette robot tool such as a pipette holder or a swab holder.
- the filtration unit further comprises a third filtering container that can be removable, said third filtration tank comprising a filtration means dividing the third filtration tank into a collection zone and a suction zone, the collection zone of the third filtration tank being in fluid communication with the suction zone of the collection tank.
- the suction means is a suction / discharge means.
- suction / discharge means any means capable of passing a liquid from the collection area of the collection tank to the suction zone of the suction collection tank and possibly the suction zone of the reservoir. collection to the collection area of the collection tank by backflow.
- the advantage of the backflow is in particular to be able to resuspend in a liquid a portion of the concentrate of constituents of interest (also called retentate) from the biological sample by detaching from the filtration means.
- a succession of suction and discharge stages also makes it possible to improve the concentration of the concentrate in the collection zone, more particularly in a preferential zone.
- This suction / discharge operation can therefore be performed several times.
- This suction / discharge operation can be carried out by adding a buffer, for example a carbonate buffer or water, in particular to carry out a washing.
- the second suction means that can be connected to the suction zone of the prefiltration tank is a suction / discharge means.
- the suction means is replaced by means for placing the collection tank and / or the prefiltration tank and / or the filtration tank in overpressure.
- the pressurizing means is therefore adapted to be connected to the collection zone of the collection tank and / or the prefiltration tank and / or the filtration tank.
- the second suction means is replaced by a second means for overpressuring the collection tank and / or the prefiltration tank.
- the second means of overpressure is adapted for this purpose to be connected to the collection zone of the collection tank and / or the prefiltration tank.
- the collection tank and / or the prefiltration tank and / or the filtration tank is closed by a closure means.
- said closure means is pierceable by a robotic robot tool, such as a pipette, a swab, a pipette holder, a swab holder, a gripping tool such as a forceps or directly by the tip of a pipetting channel integrated in the robot.
- said closure means is removable by a robotic robot tool, for example a gripping tool such as a clamp, a pipette holder or a swab holder.
- the invention also relates to the use of a device according to any one of the various embodiments presented for the treatment of a biological sample.
- the subject of the invention is also a method for treating a biological sample using a device according to any one of the various embodiments presented, comprising the following steps:
- the subject of the invention is a method for treating a biological sample with the aid of a device according to the invention comprising the following steps:
- the subject of the invention is a method of treating a biological sample with the aid of a device according to the invention comprising the following steps:
- the subject of the invention is a method for treating a biological sample with the aid of a device according to the invention as described above, further comprising a step consisting of:
- the subject of the invention is a method of treating a biological sample with the aid of a device according to the invention as described above, including the step of:
- the invented device allows easy access to the filtration means of the collection tank, for example to the membrane, in order to carry out washes or collect microorganisms, for example by resuspension by pipette or by swabbing.
- the inclination of the second plane in which the filtering means of the collection tank extends with respect to the plane of the base of the fixed support can be obtained by the geometry of the fixed support on which the filtration unit is arranged and / or by inclination of the filtration means.
- the fixed support may comprise a plane inclined relative to its base, the latter being horizontal, the filtration unit being disposed on this inclined plane and the filtering means of the collection tank s' extending in a plane parallel to this inclined plane.
- the inclination of the second plane in which the filtering means of the collection tank extends relative to the plane of the base of the fixed support is fixed throughout the filtration step.
- the shape of the wall of the collection tank makes it possible, in cooperation with the inclination of the second plane in which the filtration means extends, to promote the retention of the biological sample in a preferential collection zone when the latter is dispensed in the collection tank.
- This preferential zone corresponding to the lower part of the filtration means.
- This preferential zone contains, following a filtration step, the majority of the concentrate of microorganisms or constituents of interest present in the biological sample.
- the suction zone is thus defined by the second plane of the filtration means is the wall of the collection tank so that the filter means is the wall of the collection tank are in contact in the preferred area.
- the advantage of this contact is to avoid the formation of dead volumes where a liquid portion of the biological sample could stagnate after the filtration step.
- Another advantage of this contact and of this preferential zone is to favor the retention of the biological sample in a delimited and predictable zone, which favors a higher recovery efficiency by a robotic robot automaton that does not have a vision system. in particular a vision system for locating a bacterial carpet on the surface of the filtration means.
- the geometry of this preferential zone can be modified according to the angle formed between the filtration means and the wall of the collection tank.
- This angle can be closed (acute) to create a localized but deep or open (obtuse) preferential zone to limit the depth of the preferential zone while enlarging the area covered by said zone for the same volume of liquid contained in this zone.
- the angle formed between the filtration means and the wall of the collection reservoir in the preferred zone is thus between 10 and 170 degrees, preferably between 30 and 150 degrees, preferably between 50 and 130 degrees, preferably between 70 and 120 degrees, more preferably between 80 and 100 degrees, more preferably between 50 and 70 degrees. Even more preferably the angle is 90 degrees. Even more preferably the angle is 60 degrees.
- the filtration means is the wall of the collection tank are in contact over the entire surface of the filtration means.
- the advantage of this contact over the entire surface of the filtration means is to limit the adhesion on the wall of any debris contained in the biological sample and to simplify the process of filtering the biological sample, which may be be distributed anywhere in the collection area of the collection tank, especially on the wall or directly on the filtering means.
- the microorganisms concentrate towards the lower part of the filtration means forming, for example, a closed angle with the wall of the collection reservoir.
- a bacterial concentrate can for example be recovered without significant loss of volume (volume recovered from 300 to 700 ⁇ ), relative to the volume of collection buffer dispensed (volume 400 to 1000 ⁇ ), a factor of 10 to 20 relative to the volume. initial biological sample.
- the inclination of the second plane of the filtration means relative to the plane of the base of the fixed support may be between 10 ° and 60 °, preferably between 20 ° and 50 °, preferably between 25 ° and 45 °, more preferably equal to 30 °.
- the device according to the invention is easily usable with an automated pipettor also called pipetting robot.
- the wall of the collection tank is adapted to be able to present vertically a pipette robot tool, such as a pipette or a swab, in line with the entire surface of the filtering means of the collection tank directly after or during filtration step.
- the interest is not to have to move the device, the collection tank and / or the filtration means to collect the concentrate of constituents of interest.
- Another advantage is to be able to collect by abrasion or detachment the concentrate of constituents of interest, such as microorganisms, deposited on all or part of the filtration means after filtration, by means of a swab.
- the shape of the wall of the collection tank is adapted so that an operator or a pipetting robot can access the entire surface of the filtering means of the collection tank, in particular in the vertical of said filtering means.
- a pipetting robot indeed has a pipette moving in translation in three degrees of freedom and not allowing to perform complex movements or to present a pipette other than vertically.
- This access to the entire surface of the filtering means of the collection tank thus makes it possible to dispense a liquid on an area of the filtration means of the collection tank of a powerful jet and then to suck up the same liquid in order to be able to re-dispense it powerfully on another area of the filtering means of the collection tank.
- a series of about twenty dispensing / re-aspirations can thus be performed in order to concentrate and then harvest the constituents of interest retained on the entire surface of the filtration means of the collection tank.
- the inclination of the collection tank also allows the collection liquid to be located in the preferential collection area by limiting the volume losses that a horizontal filtration system would generate.
- the wall of the collection tank may have at least one inclined or ogival-shaped part adapted to be able to vertically present a pipette, in line with the concentrate of constituents of interest, in particular microorganisms, the concentrate being mostly located in the preferential zone.
- This geometry also facilitates pipetting and / or swabbing operations, manual and / or automatic, in particular by avoiding striking the wall of the collection tank.
- the advantage of such a device is that it can be used, on the same type of device, for different types of biological samples (urine, blood cultures, etc.) of different volumes (10 ml to 1 ml), selecting a treatment protocol adapted to the biological sample considered.
- the protocol is a selective lysis followed by a single filtration on a filtering means, for example a membrane.
- the protocol consists of prefiltration on the filtration means of the prefiltration tank, followed by filtration on the filtering means of the collection tank, for example on a membrane.
- the two protocols can advantageously be followed by one or more washing steps of the bacterial concentrate, using suitable washing solutions.
- ITRV Identification Typing Resistance Virulence
- ESI ElectronSpray ionization mass spectrometry
- the advantage of such a device is also to be disposable.
- the materials used for its realization being inexpensive, the device and / or the filtration unit and / or the prefiltration tank may be disposable for the treatment of a sample.
- the filtration unit is removable.
- the filtration unit is removable and disposable.
- the prefiltration tank can also be removable.
- the prefiltration tank is removable and disposable.
- the device can also be used for automatic plate preparation
- the microorganisms can for example be collected directly on the filtration means of the collection tank by a robotic tool to be deposited on a MALDI-TOF plate or used for the preparation of a concentrated and calibrated suspension of microorganisms.
- the microorganisms can be arranged in a liquid suspension which will be centrifuged in order to be able to recover a pellet of microorganisms. This pellet of microorganisms will then be deposited on a MALDI-TOF plate.
- FIG. 1 is a device of the prior art
- Figure 2 is a schematic sectional representation of a first embodiment of the device according to the invention comprising a filter unit on a fixed support inclined at 30 °.
- Figure 3 is a schematic sectional representation of the filter unit, according to the first embodiment.
- Figure 4 is a schematic perspective representation of the first embodiment of the device according to the invention.
- Figure 5 is a schematic bottom view of the filter block, according to the first embodiment.
- Figure 6 is a schematic top view of the filter unit, according to the first embodiment.
- Figure 7 is a schematic perspective representation of the fixed support inclined at 30 °, according to the first embodiment.
- Figure 8 is a photograph of the first embodiment of the device according to the invention.
- Figure 9 is a schematic perspective representation of a second embodiment of the device comprising a slider support.
- Figure 10 is a schematic sectional representation of the second embodiment of the device.
- FIG. 11 is a schematic representation in section of Detail A of the second embodiment of the device, as represented in FIG.
- FIG. 12 is a schematic sectional representation of Detail B of the second embodiment of the device, as shown in FIG.
- Figure 13 is a schematic perspective view of the prefilter holder of the second embodiment of the device.
- FIG. 14 is a diagrammatic representation in perspective and in section of the second embodiment of the device having the suction flows "A" and "B".
- FIG. 15 is a diagrammatic representation in perspective and in section of the second embodiment of the device without the pre-filtration stage having the suction flow "B" in this use.
- Figure 16 is a schematic sectional representation of the second embodiment of the device without the prefiltration stage, combined with a pipetting device.
- FIG. 17 is a graph illustrating the pre-filtration rates obtained using the device according to the invention for the treatment of different samples of inoculated urine.
- Figure 18 shows three graphs showing the detection in ESI-MS of specific peptides of the inoculated species in blood culture bottles compared to a negative control (sterile blood cultures). This figure 18 illustrates an experiment using the device according to the invention for the treatment of samples of inoculated blood cultures.
- the collection tank is accessible without removing the prefiltration tank.
- the device according to the invention can thus be placed in a pipetting robot, which will discharge the biological sample into the pre-filtration tank if pre-filtration is necessary, or in the collection tank if filtration is sufficient.
- Such a device is therefore able to process biological samples of different kinds, such as urine or blood, without having to manipulate the prefiltration reservoir.
- the suction zone of the prefiltration tank is in fluid communication with the collection area of the collection tank.
- the device 100 is composed of a fixed support 1 inclined at 30 ° on which is installed a filtering unit 2 that can be removable.
- the filtration unit 2 comprises a filtration means also called prefilter or a stack of prefilters 3 contained in a pre-filtration tank 4 and which clarifies the solutions to be filtered without retaining the microorganisms.
- the filtration unit also comprises a collection tank 5 with a filtration means, for example a membrane 6 disposed in the bottom of the tank.
- the angle of 30 ° between the plane along which the filtering means of the collection tank extends and the plane of the base 1 of the fixed support 1 is obtained by an inclination of the fixed support 1 and / or the block filtration 2 and / or the membrane 6.
- the collection reservoir 5 has at least one wall of which at least a portion is inclined 1 January.
- the collection tank 5 is closed by a sealing means.
- This sealing means is for example constituted by a lidding film 50, as shown in FIG. 2.
- This lidding film makes it possible to maintain a low pressure state downstream of the prefilter (s) during the operation. filtration of complex media such as urine.
- the lidding film 50 may be a self-adhesive film, in particular of the oriented bi-axial polypropylene (BOPP) type, polyethylene terephthalate (PET), polyester (PE), aluminum / PE type.
- BOPP oriented bi-axial polypropylene
- PET polyethylene terephthalate
- PET polyester
- PE aluminum / PE type.
- Such a sticker film can be taken off easily by an operator or by means of an automaton.
- the film can be welded to the filtration unit 2 by any appropriate means (ultrasonic welding, heat sealing, etc.). Such a film is then drilled for a suitable tool, which can cooperate with the toolholder of an automaton.
- a suitable tool is a pipette robot tool, such as a pipette door, a swab holder, a gripping tool such as a clamp or directly through the tip of a pipetting channel integrated in the robot.
- the device and / or the filtration unit and / or the prefiltration tank may be disposable. Even more advantageously, the filtration unit is removable. Even more advantageously, the filtration unit is removable and disposable.
- the prefiltration tank can also be removable.
- the prefiltration tank is removable and disposable.
- the closure means may be constituted by a piece of plastic lid type having a suitable opening mechanism, to ensure the necessary seal when positioned on the collection tank 5, for generate the low pressure state while allowing when it is relieved to be able to access the collection tank.
- the device is connected to a vacuum suction system (for example a pump), not shown, and a bin that collects the filtered liquids.
- a vacuum suction system for example a pump
- the suction is made through the suction ports of the prefilter 7 and the membrane 8 located on the fixed support 1.
- the seal between the filtration unit 2 and the fixed support 1 can be obtained by any appropriate means.
- the filtration unit 2 is screwed onto the fixed support 1 and a seal, not shown, is placed between the filtration unit 2 and the fixed support 1
- a valve allows to manage the protocol by aspirating either at the prefilter 3, or at the membrane 6 (or in continuous suction downstream of the membrane and alternating suction downstream of the prefilter).
- the valve can be integrated into the vacuum suction system or be an integral part of the filtration device.
- the filtration unit 2 can be removable.
- the suction orifice of the prefilter 7 is in fluid communication with the suction zone of the prefiltration tank 4 via an orifice 71 on the filtration unit 2 when it is disposed on the fixed support 1.
- the suction port 8 of the membrane communicates with the open portion 81 of the collection tank 5 it even in fluid communication with the suction zone of the collection tank 5.
- the collection reservoir 5 has at least one wall of which at least one part 1 1 is inclined.
- a valve not shown, makes it possible to manage the protocol by sucking, either downstream of the prefilter 3, either downstream of the membrane (either continuous suction downstream of the membrane and alternating suction downstream of the prefilter).
- the liquid to be treated for example urine
- the vacuum pump is turned on.
- the valve is set to suck through the prefilter 3 via the suction port of the prefilter 7 and, if appropriate, the orifice 71.
- the valve is set to suck at said membrane 6 via the suction orifice of the membrane 8 and, where appropriate, the opening portion 81 of the collection tank 5.
- the microorganisms are collected on the membrane 6.
- the porosity of this membrane is less than the diameter of the microorganisms to be collected.
- the porosity is between 0.22 and 0.45 ⁇ .
- the membrane can be washed to purify the microorganisms.
- the wall of the collection tank 5 comprises at least one inclined part 1 1 or at least one ogival-shaped part.
- This shape of the wall makes it possible, in cooperation with the inclination of the membrane 6, to favor the retention of the microorganisms in a preferential zone corresponding to the lower part of the filtration means 3. This part then forms an acute angle between the means of filtration 3 and the wall of the collection tank 5.
- this retention of microorganisms in a preferential zone makes it possible to locate the microorganisms in a delimited and predictable zone, which favors a higher recovery efficiency by a PLC that does not have a vision system for locating a bacterial mat on the surface of the membrane.
- the vacuum pump is extinguished in order to reduce the pressure downstream of the membrane 6 at atmospheric pressure.
- the microorganisms then adhere to the membrane 6 and can be recovered / collected in various ways and in a nonlimiting manner:
- the collection reservoir 5 advantageously has at least one wall, at least a portion of which is inclined to 1 1 so as to allow the pipette 10 presented vertically to collect microorganisms collected on the entire surface of the membrane 6, without hitting the wall of the collection tank 5;
- the advantage of such a device is to be able to suck the liquid through the pipetting cone, through the porous portion of the swab, then to come into contact with the membrane, or any filtration means of the collection tank to "peel off" the microorganism concentrate by abrasion, this operation not being feasible with the conventional end of a pipetting cone; ⁇ By directly recovering membrane 6 and resuspended in a tube or direct lysis of microorganisms. The membrane 6 is then removably mounted in the collection tank 5;
- the various recovery / collection methods may be adapted depending on the microorganisms sought or the type of sample. Indeed, some microorganism concentrate has a very strong adhesion to the membrane. The collection of microorganisms is then impossible by fast ejection of a liquid, the jet of liquid is not powerful enough to take off the concentrate. Only an abrasion technique (using a swab or a pipetting cone wrapped by the porous part of a swab at its end) is then effective to detach the concentrate from the membrane.
- FIG. 9 A second embodiment is illustrated in Figure 9.
- the prefiltration tank must be removed in order to access the collection tank.
- the prefiltration tank is for example stacked on the collection tank.
- Such a device is therefore able to process biological samples of different kinds, such as urine or blood, while being compact.
- the suction zone of the prefiltration tank is in fluid communication with the collection area of the collection tank.
- the device is composed of a fixed support 20 on which is installed a filter unit 22 that can be removable.
- the filtration unit 22 is held on the support 20 by means of two sliders 23.
- the device is connected to a vacuum suction system (for example a pump), not shown, and a bin that collects filtered liquids. Suction is through the suction ports of the prefilter 24 and the suction port of the membrane 25 located on the fixed support 20.
- the fixed support 20 thus comprises a plurality of suction orifices forming two circuits. aspiration marked by arrows "A" and "B".
- the two suction circuits thus make it possible to suck downstream of the membrane and / or downstream of the prefilter independently, via the suction zones of the collection and pre-filtration tanks.
- the device can be held on the support without the use of slides.
- the seal between the filtration unit 22 and the fixed support 20 can be obtained by any means.
- the filtration unit 22 is held on the fixed support 20 and two O-rings, not shown, are placed between the filtration unit 22 and the fixed support 20 to seal the suction circuits "suction A" and "suction B".
- the filtration unit 22 comprises a filter means, also called prefilter or a stack of prefilters 26, contained in a pre-filtration tank 28 and which clarifies the solutions to be filtered without retaining the microorganisms.
- the filtration unit 22 also comprises a collection tank 30, a filtration means, for example a membrane 32, disposed in the bottom of the collection tank 30.
- the membrane 32 is inclined at an angle of 30 ° with respect to the plane formed by the base 200 of the fixed support 20, that is 60 ° relative to the vertical.
- the collection reservoir 30 has at least one wall of which at least one portion 34 is inclined or ogival-shaped.
- the filter unit 22 can be removable, the suction port of the prefilter 24 then cooperates with a hole 24-i on the filter unit 22. Similarly, the suction port of the membrane 25 cooperates with the part opening of the collection tank 25i.
- a valve not shown (integrated or not in the device), manages the protocol by sucking either downstream of the prefilter 26, or downstream of the membrane 32 (or continuous suction downstream of the membrane 32 and alternately aspirated downstream of prefilter 26.
- the collection reservoir 30 can be made in two assembled parts 36 and 38.
- the upper portion 36 and the lower portion 38 cooperate to maintain the membrane 32 in place. position, for example by means of two lugs 40.
- the two parts 36 and 38 are welded to maintain the membrane.
- prefiltration tank 28 can be made in two assembled parts, an upper part 42 and a lower part 44 which serves as a support for pre-filter 26.
- the upper part 42 and the pre-filter support 44 cooperate to maintain the prefilter 26 in position.
- the upper portion 42 comprises a means 33 engageable with a pipette tool of a pipetting robot.
- the means 33 may also take a suitable form (for example one or more holes or pin (s)) to be handled automatically by a mechanical element (such as a clamp), a gripping tool for pipetting robot, a pipette door, a swab holder, or directly by the tip of a pipetting channel integrated in the robot.
- this means 33 may comprise a cylindrical part in which the pipette-holder tool can be inserted and maintained in such a way as to lift the prefiltration reservoir 28 and thus free access to the membrane 32.
- this cylindrical portion is held by a set of ribs arranged radially on the cylindrical portion so as to define at least one means of access access to the prefilter or stack of prefilters 26.
- This access means allowing an apparatus such as a pipetting robot to present a tool vertically to the prefilter or the prefilter stack to dispense a liquid therefrom ( eg the sample to be treated) without handling or hitting the upper part 42.
- the pre-filter support 44 may have projections 46 extending radially with respect to the suction orifice 45 of the pre-filter support 44.
- the projections 46 are arranged on the face facing the prefilter, to maintain the pre-filter in position while facilitating the flow of the filtrate.
- the protrusions 46 extend radially with respect to the suction orifice 45 and in one or more concentric circles concentric with the suction orifice 45.
- the prefilter support 44 makes it possible at the same time to support the prefilter or the stack of prefilters 26 and ensure the sealing of the collection tank during the evacuation of the reservoir, thus allowing the effective passage of the sample through the prefilter or the stack of prefilters 26.
- a urine sample filtration protocol using the second embodiment of the device comprises the following steps
- 1 st step Dump urine on the pre-filter 26.
- urine can be discharged by a pipettor robot stand from the vertical pre-filter 26 through the access means the prefilter 42.
- the urine can be spilled, manually or automatically, directly on the prefilter 26 in the case where the upper portion 42 is not present.
- 3rd step Enable suction "B” through the suction ports 25 and 25i.
- the microorganisms remain on the membrane 32 while the "waste” is sucked into the trash.
- 5 th step Optionally perform one or more washing steps of the membrane and the microorganisms distributing pipetted (manual or automated) of volumes of buffer.
- the microorganisms are then concentrated by the force of gravity and the action of the suction in the lower part of the slope formed by the membrane 32 and the wall of the collection tank 30, the latter advantageously comprising an inclined shape 34 or warhead.
- the microorganisms are then concentrated in a defined zone, corresponding to the preferential collection zone, to allow the recovery of microorganisms by an automatic pipetting robot in a reduced volume of liquid.
- the step of recovery / collection of microorganisms on the membrane 32 may be performed by the same means as those stated for the first embodiment of the device according to the invention.
- a pre-lysed blood sample filtration protocol using the second embodiment of the device without prefiltration reservoir 28 comprises the following steps
- the microorganisms remain on the membrane 32 while the "waste" is sucked into the trash.
- 3rd step If necessary carrying out one or more washing steps of the membrane and the microorganisms distributing pipetted (manual or automated) buffer volumes.
- the recovery of microorganisms can be done by resuspension with the pipette 48 with a liquid (rapid ejection of the liquid, for example a neutral buffer, buffer with detergents or solvent).
- the collection reservoir 30 may have at least one wall, at least a portion of which is inclined 34 so as to allow a vertical pipette 48 to collect microorganisms collected over the entire surface of the membrane 32 without striking the reservoir wall 30.
- the device according to the invention may also be used with a swab for the collection of concentrated microorganisms and retained on the filtering means of the collection tank. for example a membrane.
- the collection by swab can be performed either manually or automatically by adapting the gripping tool of a robotic robot.
- the device according to the invention also functions with different types of filters used in the prefiltration tank or collection tank, alone or stacked, and different membranes alone or stacked.
- the prefiltration tank is not useful.
- the samples are directly deposited above the filtering means of the collection tank, for example on a filtration membrane, more particularly on a membrane of 0.2 ⁇ of porosity.
- the prefiltration tank can be removed by a pipette tool or swab holder for robot pipettor.
- filtering materials that can be used as filtering means are given by way of example in Table 1.
- the size of the pores is adapted according to the size of the debris. filter.
- the pore size of the material used as a filter medium can be up to 1 mm to filter large debris.
- the filtration means of the prefiltration tank also called prefilters or stacks of prefilters used in the device according to the invention are also given below.
- the materials used as a means of filtering the reservoir of Pre-filtration can be used as a means of filtering the collection tank, alone or stacked.
- the device according to the invention also called dual-filtration device and as described above is here applied to the treatment of inoculated urine.
- Comparative Table 2 for each filtering means of the prefiltration tank, 9 ml of a set of mixed urine samples consisting of 10 pathological urinary tubes is introduced onto the filtering means in the prefiltration tank in which is evacuated gently by means of a three-way valve.
- the three-way valve is slowly switched to the Filter position to pass the urine through the filtering means of the collection tank, here a 0.45 ⁇ PES membrane.
- the valve is returned to the closed position.
- the bacterial pellet is washed on the membrane with 1 ml of 50 mM carbonate buffer pH8 (open filter valve) and is then recovered with 400 ⁇ l of carbonate buffer (vacuum stopped and device put back to atmospheric pressure); the recovered volume varies from 300 to 400 ⁇ .
- the volume collected was divided into two parts, part of which was used to carry out a protein assay after lysis (P2 lysis protocol).
- the polymicrobial urines contained mainly:
- Comparative Table 2 summarizes the observations made during the tests as well as the results of counting the number of CFUs by counting on bioMérieux chromlD® CPS agar plates and the protein assay results.
- the stacks of prefilters that can be used as filtration means of the prefiltration tank are:
- the membranes that can be used, in particular as filtering means for the collection tank are:
- Polyethersulfone PES
- Nylon Polyamide
- Polytetrafluoroethylen PTFE
- Polycarbonate Polyester
- Cellulose Regenerated Cellulose, Cellulose Acetate, Cellulose Nitrate, Mixed Cellulose Ester
- Type Anopore membranes (Anodisc) made of aluminum oxide with a porosity of 0.02 ⁇ (for exosome purification type applications)
- Filtration membranes may be low silica materials, polymers, acetate or oxide of alumina by way of example.
- the porosity of the filtration means used in the device according to the invention will be easily adapted by those skilled in the art according to the constituents of interest sought in the biological sample.
- the swabs that can be used in combination with the use of a pipetting cone are:
- the porous portion of the swab is dissociated from the handle to come wrap the opening portion, usually pipetting the liquid, a pipetting cone.
- the collection tank filtration means extending in a second plane can be inclined at an angle other than 30 °, that is between 10 and 60 ° (which corresponds to an angle between 30 to 80 ° relative to the vertical ) with respect to the plane formed by the base of the fixed support. This while allowing the concentration of samples and their collection by a collection means such as a pipette or a swab.
- the device may be provided with a third reservoir comprising a third filtering means.
- a third reservoir comprising a third filtering means.
- This is to achieve a new filtration stage for desired compounds whose size is between 0.02 and 0.2 ⁇ such as micro-vesicles or exosomes.
- the device and corresponding method can be used to collect microorganisms automatically from urine and blood culture samples as well as to extract small biological elements such as exosomes or microvesicles.
- the device can thus be used in the field of oncology by allowing for example to concentrate the exosomes (90 nm in diameter), known as cancer marker.
- the added value is to propose a fast, generic and simple process for extracting exosomes or microvesicles from saliva, serum or plasma samples.
- the filtration means of the collection tank is a membrane of porosity 0.02 ⁇ .
- another embodiment comprises a third reservoir containing a third filtering means downstream of the filtering means of the collection reservoir comprising a porosity membrane of 0.02 ⁇ .
- Example 1 Inoculated urine experiments: Results on the three microorganisms in automatic mode
- Microorganisms EC Erscherichia coli
- SE Staphilococcus epidermidis
- CA Candida albicans
- the yield is defined as the ratio of the amount of microorganisms recovered on the membrane at the end of the protocol on the amount of microorganism introduced into solution on the prefilter.
- Example 2 Inoculated healthy urine experiments: on a pipettor automaton (4 parallel devices). Filtration efficiency on microorganisms EC (Escherichia coli) and CA (Candida albicans) for different configurations (volume and distance to the vertical of the filter) resuspension.
- EC Erichia coli
- CA Candida albicans
- Table 4 showing the recovery performance of EC and CA microorganisms on multiple replicates by varying the automated resuspension method.
- the filtration means of the prefiltration tank consists of a stack of pre-filters (order from the bottom upwards, the prefilter placed at the top being the first to receive the liquid): nylon 30 um / 2x VFE 5um / filtrona 2 mm or 4 mm (ie 2x2 mm) and filter means of the collection tank a membrane PES 0.45 um (Pall).
- the sequence of pre-filtration / filtration steps for 6 to 10 mL of urine is carried out at most in 3 minutes.
- the concentrate was collected by resuspension in 400 ⁇ l of carbonate buffer and then subjected to the lysis-digestion protocol (manual version) to be injected into LC-ESI MS with a method of acquisition developed in a non-optimized way to search for peptides found in E.Coli.
- the MRM method targets 60 peptides, 7 of which are specific to the E. coli species and 9 common to the Enterobacteriaceae family, the remaining 44 must be generic to the Gram-.
- Table 5 shows that after the double filtration treatment of urine of very different compositions (amount of white blood cells, red cells, epithelial cells), the specific peptides of E. coli are generally well detected for the urine containing the urine.
- E.coli species from the identification results on a bioMérieux VITEK®2 automated device provided.
- the detection of peptides common to enterobacteria is also correct since the species E.coli belongs to this family.
- Urines u10 and u13 containing bacteria of the enterobacteria family do indeed have peptides specific for this family without the presence of peptides specific for E. coli.
- U9 urine identified C.Koseri results in the detection of peptides specific for E. coli and peptides common to the Enterobacteriaceae family. This presence of an E. coli population together with C. Koseri colonies is also observed on bioMérieux ChromlD® CPS culture medium.
- Table 6 gives the good identification scores of the E. coli species in a first batch of pathological urines.
- the bacterial pellet was deposited on a MALDI-TOF target before addition of the ⁇ -cyano-4-hydroxycinnamic acid matrix (HCCA matrix) or with the addition of formic acid (AF), drying then addition of the HCCA matrix.
- the MALDI-TOF spectra were obtained with a Shimadzu spectrometer controlled by Launchpad (bioMérieux VITEK® MS device). The results of identifications given according to Table 8 were obtained by interrogation of the database "bacteria”.
- the lysis-filtration protocol briefly consists of selective lysis of the blood cells by the action of a buffer containing a surfactant for a short time.
- the advantage provided by the device described above is its geometry, here an inclination of the filtration means of the collection tank of 30 °, which allows the efficient harvesting of microorganisms by means of a liquid solution leading finally to a bacterial suspension.
- the Lyse-filtration protocol is as follows:
- Filtration is carried out on a 0.2 ⁇ PES filtration membrane used as a means of filtering the collection tank on the device according to the invention.
- test portion is 0.8 mL of blood culture which are treated with 0.4 mL of 0.3 M CAPS buffer / 0.45% Brij for 2 minutes followed by filtration for 2 minutes.
- Figure 18 shows the detection results via the MRM methods adapted to the microorganism inoculated in the bottles of blood cultures.
- the three graphs show for microorganisms 3 good detection of specific peptides in the positive samples on day 0 post cultivation (EC1 J 0, EC2 J 0, CA1 J 0, CA2 J 0, CA3 J 0, SE1 J 0 SE2 J 0 , SE 3 J 0 ).
- a minor number of peptides (2-4) are detected in negative controls (Cneg). The significant difference between the number of peptides detected and the cumulative area between the positive samples and the negative controls indicates that the protocol performed on the device described makes it possible to harvest the bacteria contained in the blood cultures.
- the filtration means of the prefiltration tank consists of a stack of prefilters.
- the prefilters used being from bottom to top: 1 x VFE 5 ⁇ m / Filtrona 2 mm.
- the filtration means of the collection tank where the bacteria will be recovered is a membrane: PES 0.45 ⁇ m (Bread
- the volume of filtered urine is between 3 and 6 mL for a filtration time of a few minutes.
- Concentrate collection is done with 1000 ⁇ of water (Versol).
- Short culture manipulation of 5:00 is done by depositing 100 ⁇ of urine and raking. After 5:00 of growth at 37 ° C, the biofilm is observed. This biofilm is then collected with a 1 ⁇ dose and placed on a MALDI-TOF target.
- Table 1 1 Codification of protocols according to the treatment carried out and the MALDI-TOF target deposition mode
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Sustainable Development (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Sampling And Sample Adjustment (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1353755A FR3005163A1 (en) | 2013-04-24 | 2013-04-24 | DEVICE FOR FILTRATION AND AUTOMATIC CONCENTRATION OF MICROORGANISMS. |
FR1359952A FR3005164B1 (en) | 2013-04-24 | 2013-10-14 | DEVICE FOR THE PREPARATION OF BIOLOGICAL SAMPLE |
PCT/FR2014/050973 WO2014174203A1 (en) | 2013-04-24 | 2014-04-22 | Device for preparing biological samples |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2989437A1 true EP2989437A1 (en) | 2016-03-02 |
Family
ID=49876856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14726695.1A Pending EP2989437A1 (en) | 2013-04-24 | 2014-04-22 | Device for preparing biological samples |
Country Status (5)
Country | Link |
---|---|
US (1) | US9957473B2 (en) |
EP (1) | EP2989437A1 (en) |
JP (1) | JP6606062B2 (en) |
FR (2) | FR3005163A1 (en) |
WO (1) | WO2014174203A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4099363A1 (en) * | 2013-06-25 | 2022-12-07 | Purdue Research Foundation | Mass spectrometry analysis of microorganisms in samples |
DE102017110476B4 (en) | 2017-05-15 | 2019-03-07 | Bruker Daltonik Gmbh | Preparation of biological cells on mass spectrometric slides for desorbing ionization |
WO2019038577A1 (en) * | 2017-08-23 | 2019-02-28 | Shehadi Imad E | A tissue processing apparatus, a filter and a method for processing tissue therefrom |
CN108896364B (en) * | 2018-06-19 | 2021-08-03 | 河北医科大学 | Centrifugal ultrafiltration device for pretreatment of feed, livestock manure and tissue sample |
CN113272047A (en) | 2019-01-16 | 2021-08-17 | 默克专利股份公司 | Filter head for vacuum filtration, manifold for vacuum filtration and method of modifying an existing filter head for vacuum filtration |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2526295B2 (en) * | 1975-06-12 | 1978-11-23 | Hoechst Ag, 6000 Frankfurt | Method of manufacturing a nutsche |
US4722792A (en) * | 1985-02-09 | 1988-02-02 | Kurashiki Boseki Kabushiki Kaisha | Filter for centrifugal separator |
DE69305947T2 (en) * | 1992-09-18 | 1997-03-13 | Amersham Int Plc | Device and method for affinity separation |
DE19725894A1 (en) * | 1997-06-19 | 1998-12-24 | Biotechnolog Forschung Gmbh | Differential vacuum chamber |
JP2000202023A (en) * | 1999-01-19 | 2000-07-25 | Fuji Photo Film Co Ltd | Blood filter |
US6458278B1 (en) * | 1999-02-22 | 2002-10-01 | Nalge Nunc International Corporation | Filtering unit having separately attachable filter cassette, filter cassette, and method of filtering |
US7211225B2 (en) * | 2002-08-26 | 2007-05-01 | Perceptronix Medical Inc. | Filter devices for depositing material and density gradients of material from sample suspension |
CA2520439A1 (en) * | 2003-03-28 | 2004-10-07 | Alza Corporation | Static diffusion cell for diffusion sampling systems |
FR2902799B1 (en) | 2006-06-27 | 2012-10-26 | Millipore Corp | METHOD AND UNIT FOR PREPARING A SAMPLE FOR THE MICROBIOLOGICAL ANALYSIS OF A LIQUID |
WO2008144083A1 (en) * | 2007-05-23 | 2008-11-27 | Nypro Inc. | Methods and apparatus for foam control in a vacuum filtration system |
AT505306B1 (en) * | 2007-07-09 | 2008-12-15 | Mbonline Gmbh | DEVICE FOR MONITORING WATER TO MICROBIAL CASES |
US8997998B2 (en) * | 2008-07-25 | 2015-04-07 | Smith & Nephew Plc | Controller for an acoustic standing wave generation device in order to prevent clogging of a filter |
JP5800910B2 (en) * | 2010-10-25 | 2015-10-28 | サイトゲン カンパニー リミテッド | Cell collection device |
JP5875787B2 (en) * | 2011-06-22 | 2016-03-02 | 株式会社日立製作所 | Microorganism recovery apparatus, microorganism recovery method, and liquid bacteria collection cartridge |
-
2013
- 2013-04-24 FR FR1353755A patent/FR3005163A1/en active Pending
- 2013-10-14 FR FR1359952A patent/FR3005164B1/en active Active
-
2014
- 2014-04-22 JP JP2016509527A patent/JP6606062B2/en active Active
- 2014-04-22 EP EP14726695.1A patent/EP2989437A1/en active Pending
- 2014-04-22 US US14/782,757 patent/US9957473B2/en active Active
- 2014-04-22 WO PCT/FR2014/050973 patent/WO2014174203A1/en active Application Filing
Non-Patent Citations (1)
Title |
---|
See references of WO2014174203A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2016518604A (en) | 2016-06-23 |
WO2014174203A4 (en) | 2014-12-18 |
FR3005163A1 (en) | 2014-10-31 |
US20160040115A1 (en) | 2016-02-11 |
FR3005164B1 (en) | 2017-03-31 |
US9957473B2 (en) | 2018-05-01 |
JP6606062B2 (en) | 2019-11-13 |
FR3005164A1 (en) | 2014-10-31 |
WO2014174203A1 (en) | 2014-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014174203A1 (en) | Device for preparing biological samples | |
EP2356210B1 (en) | Automated system for the lysis of microorganisms in a sample, and for the extraction and purification of the nucleic acids of said microorganisms for analysis | |
AU2011343588B2 (en) | Methods for the isolation, accumulation characterization and/or identification of microorganisms using a filtration and sample transfer device | |
EP2152850B1 (en) | Device for the lysis of microorganisms present in an environmental or clinical sample and the extraction of nucleic acids from said microorganisms for analysis | |
EP1866091B1 (en) | Method and device for the separation of biological particles contained in a liquid by means of vertical filtration | |
JP4150187B2 (en) | Method and apparatus for plasmid recovery using ultrafiltration | |
FR2902799A1 (en) | METHOD AND UNIT FOR PREPARING A SAMPLE FOR THE MICROBIOLOGICAL ANALYSIS OF A LIQUID | |
EP3541517B1 (en) | Extraction system and method for extracting microorganisms contained in a sample | |
US20130045532A1 (en) | Methods and kits for isolating microorganisms from culture | |
EP3629000B1 (en) | Method for preparing a biological sample | |
AU4960399A (en) | Filtration and extraction device and method of using the same | |
EP2872867B1 (en) | Automated system for the lysis of microorganisms present in a sample, for extraction and for purification of the nucleic acids of said microorganisms for purposes of analysis | |
CN113329820B (en) | Method and apparatus for selectively extracting components from biological samples | |
FR2748569A1 (en) | METHOD AND PLANT FOR SEPARATING MAGNETIC PARTICLES IN A FLUID FOR BIOLOGICAL ANALYSIS, AND APPLICATION OF SAID METHOD | |
FR3034519A1 (en) | DEVICE, KIT AND METHOD FOR COLLECTING AND PROCESSING A BIOLOGICAL SAMPLE | |
EP1287112B1 (en) | Preparing a sample to be analysed from a sample with very large volume | |
EP3766580B1 (en) | Microfluidic device for preparing and analysing a biological sample | |
EP3030910B1 (en) | Method and device for washing a pipetting-dispensing device | |
FR2848224A1 (en) | Detecting microrganisms in liquid samples, useful e.g. for detecting pathogens in water, includes preliminary concentration with a tangential flow filtration device | |
CA3150552A1 (en) | Device containing glass beads functionalized with polyethyleneimine, and use thereof for capturing microorganisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20151012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: ROSTAING, HERVE Inventor name: BROYER, PATRICK Inventor name: VERON, LAURENT |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20210310 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20240531 |